Neurovalens

Verwendung der Mittel

US expansion; scale sales of existing FDA‑approved devices; pursue further regulatory approvals and clinical/regulatory studies; expand distribution, commercialization and reimbursement/B2B partnerships; hire commercial and regulatory resources.

Lead Investor

Alle Investoren (5)

• Investment Fund for Northern Ireland (IFNI)Lead
• Whiterock (Growth Capital Fund / Whiterock Finance)
• IQ Capital
• Innovation Ulster Ltd
• Angel CoFund (jetzt ACF Investors / früher Angel CoFund)

Analyse-Artikel

Neurovalens schließt 6‑Mio.-£‑Runde unter Führung des Investment Fund for Northern Ireland

Artikel lesen